Latest Nursing research Stories
ROSEMONT, Ill., Feb, 14, 2013 /PRNewswire-USNewswire/ -- The Collaborative Spine Research Foundation (Collaborative Spine) announced today an agreement to receive up to $7 million over the next three years to fund cross-disciplinary spinal research from Medtronic's Spine business. The final amount of the grant will be contingent on Collaborative Spine's ability to engage additional industry support for its research agenda. Collaborative Spine will use the funding to award competitive,...
VANCOUVER, British Columbia and MENLO PARK, Calif., Feb. 11, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the third closing in a private placement consisting of approximately 1.2 million units of its securities to qualified accredited investors, for gross proceeds of approximately $1.0 million. The total amount raised in the private placement is $7.9 million. Charles Vista, LLC acted as the company's placement agent in the unit...
New survey focuses on clinical communications challenges, tools SARASOTA, Fla. (PRWEB) January 24, 2013 Voalte, the leader in clinical communications, and American Nurse Today, the official journal of the American Nurses Association, have partnered to conduct the first clinical communications survey to help the healthcare world better understand the voice of the bedside clinician. The 2013 Clinical Communications Survey will examine the current communications challenges faced by staff...
CLEVELAND, Jan. 7, 2013 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced it will soon be trading as DTRK. The new symbol more closely aligns with the company name and will be active January 9, 2013. (Logo: http://photos.prnewswire.com/prnh/20130107/CL38347LOGO ) "Changing our stock symbol is just one small part of...
SAN DIEGO, Jan. 3, 2013 /PRNewswire/ -- Obalon Therapeutics, Inc. (www.obalon.com) today announced that it has received a strategic investment from AMOREPACIFIC Ventures and has entered into an exclusive international distributorship agreement with PacificPharma, an AMOREPACIFIC Group subsidiary, for its novel non-surgical device for weight loss. Obalon has granted PacificPharma exclusive rights to market and distribute Obalon's device for weight loss in South Korea, subject to...
Companies with upcoming events to watch include Hyperion, Raptor and Threshold Pharmaceuticals Norwood, MA (PRWEB) December 18, 2012 BioPharm Insight’s monthly Catalyst Monitor analyzes the most material events in the sector during the upcoming month. The Catalyst Monitor tracks significant events and announcements such as FDA approvals, Advisory Committee (AdCom) meetings and expected key clinical results. To access the entire 29-page report, featuring proprietary investigative...
WINNIPEG, Manitoba, Dec. 11, 2012 /PRNewswire/ -- Doug Broeska, Ph.D., CEO of Regenetek Research Inc., an international medical research company with offices in Canada and India has announced that they are launching new web-based, self-managing, clinical trial software that amongst other things will be able to extend patient Registry information into individual patient case studies and aggregate the data with comparisons to cohorts. The company has so far specifically focused their...
63% of American respondents presenting at the American Society of Hematology annual meeting used NIH funding to support their study ATLANTA, Dec. 10, 2012 /PRNewswire-USNewswire/ -- A survey highlighting the correlation between today's cutting edge medical research and the National Institutes of Health (NIH) funding was released today at the 54th Annual Meeting of the American Society of Hematology (ASH), the preeminent medical meeting for physicians and scientists in hematology...
The Associated Medical Schools of New York (AMSNY) today directed a letter to the New York State Congressional Delegation calling on them to reject a nearly 10-percent cut to the National Institutes of Health (NIH), Medicare and Title VII health professions programs, that will take effect January 2, 2013. "In order to meet the health challenges of an aging and increasingly diverse population, continue to foster the types of innovation that will drive our regional economy, and remain a...
Although the majority do have practical concerns over patient confidentiality and recognition Nearly nine out of ten clinicians carrying out biomedical research trials believe that trial data should be shared more easily, even though they do express some practical concerns, a study published today on bmj.com reveals. BMJ has long championed transparency in medical research. Last month, the journal launched an open data campaign to compel greater accountability in healthcare, and from...
